PRAME and melanoma: Preferentially expressed antigen in melanoma (PRAME), a marker that was developed primarily for the diagnosis of melanoma, is a nuclear receptor, transcriptional regulator, and a member of the cancer testis antigen family of proteins that regulates cell differentiation, growth, and apoptosis.